The Salmonella Type III Effector SspH2 Specifically Exploits the NLR Co-chaperone Activity of SGT1 to Subvert Immunity
Amit P. Bhavsar(University of Alberta), B. Brett Finlay(University of British Columbia), Jan Stoepel(University of British Columbia), Colin J.D. Ross(BC Children's Hospital), Koshi Imami(Max Delbrück Center), Leonard J. Foster(University of British Columbia), Michael R. Hayden(University of British Columbia), Dale D. O. Martin(University of Waterloo), Karolynn Hsu(University of British Columbia), Xin Li(Zhejiang A & F University), Nat F. Brown(University of British Columbia), Phil Hieter(University of British Columbia), Marcel Wiermer(University of British Columbia)
Cited by 111
Related Papers
PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes
|Bioinformatics|2010|2.6k
Huntington disease
|Nature Reviews Disease Primers|2015|1.6k
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
|Nature Genetics|2003|976
Early life antibiotic‐driven changes in microbiota enhance susceptibility to allergic asthma
|EMBO Reports|2012|887
Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors
|Proceedings of the National Academy of Sciences|2003|836